Tuagon, Mark Jade P.
HRN: 19-96-54 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2026
CEFUROXIME 1.5GM (VIAL)
01/02/2026
01/08/2026
IV
580mg
Q8
AGE, URTI
Checking Final Appropriateness